Tumour suppressor genes in sporadic epithelial ovarian cancer
- PMID: 11882011
- DOI: 10.1530/rep.0.1230341
Tumour suppressor genes in sporadic epithelial ovarian cancer
Abstract
Ovarian cancer is the most frequent cause of death from gynaecological malignancies in the western world, and sporadic epithelial ovarian cancer is its most predominant form. The aetiology of sporadic ovarian cancer remains unknown. Genetic studies have enabled a better understanding of the evolution of tumour progression. A major focus of research has been to identify tumour suppressor genes implicated in sporadic ovarian cancer over the past decade. Several tumour suppressor genes have been identified by strategies such as positional cloning and differential expression display. Further research is warranted to understand fully their contribution to the pathogenesis of sporadic ovarian cancer.
Similar articles
-
Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.Cancer. 2001 Aug 15;92(4):787-95. doi: 10.1002/1097-0142(20010815)92:4<787::aid-cncr1384>3.0.co;2-4. Cancer. 2001. PMID: 11550149
-
[Inactivation of BRCA1, BRCA2 and p53 genes in sporadic ovarian cancer].Ceska Gynekol. 2008 Oct;73(5):298-302. Ceska Gynekol. 2008. PMID: 19110958 Czech.
-
Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.Mol Pathol. 2002 Oct;55(5):305-9. doi: 10.1136/mp.55.5.305. Mol Pathol. 2002. PMID: 12354934 Free PMC article.
-
The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer.Reprod Biol Endocrinol. 2003 Oct 7;1:72. doi: 10.1186/1477-7827-1-72. Reprod Biol Endocrinol. 2003. PMID: 14613551 Free PMC article. Review.
-
Mutations of the BRCA1 gene in human cancer.Semin Cancer Biol. 1996 Feb;7(1):33-40. doi: 10.1006/scbi.1996.0005. Semin Cancer Biol. 1996. PMID: 8695765 Review.
Cited by
-
Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis.J Cell Physiol. 2014 Apr;229(4):393-406. doi: 10.1002/jcp.24466. J Cell Physiol. 2014. PMID: 24105793 Free PMC article. Review.
-
E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer.BMC Cancer. 2010 Feb 24;10:64. doi: 10.1186/1471-2407-10-64. BMC Cancer. 2010. PMID: 20181230 Free PMC article.
-
Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.Br J Cancer. 2003 Jan 27;88(2):270-6. doi: 10.1038/sj.bjc.6600674. Br J Cancer. 2003. PMID: 12610513 Free PMC article.
-
Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy.Br J Cancer. 2005 Apr 25;92(8):1561-73. doi: 10.1038/sj.bjc.6602480. Br J Cancer. 2005. PMID: 15785748 Free PMC article.
-
Large-scale genomic analysis of ovarian carcinomas.Mol Oncol. 2009 Apr;3(2):157-64. doi: 10.1016/j.molonc.2008.12.005. Epub 2008 Dec 24. Mol Oncol. 2009. PMID: 19383377 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous